Michael Sennett

Jones Day (Chicago)
Lawyer (Partner)

Mike Sennett is partner at Jones Day (Chicago). He practices antitrust law with an emphasis on the antitrust aspects of mergers, acquisitions, and joint ventures; antitrust litigation; civil investigations before the United States Department of Justice, the Federal Trade Commission, and state attorneys general; and criminal and cartel antitrust matters, including grand jury proceedings. Mike handles complex antitrust cases in courts throughout the United States, including before the Judicial Panel on Multidistrict Litigation, and antitrust enforcement matters with the competition agencies. He also counsels clients on the antitrust aspects of intellectual property licensing and related patent matters, strategic alliances and collaborations, pricing and price discrimination, distribution, advertising and marketing practices, as well as Hatch-Waxman Act strategies. Mike Sennett serves as antitrust counsel to a number of multinational corporations and businesses operating domestically and globally. His industry experience includes pharmaceuticals, biotechnologies, medical devices, pharmaceutical benefit services, steel, automotive, building products, farm equipment, consumer products, mining, water and wastewater technologies and services, health care services, transportation, financial services, and communications. Representative corporate clients include Arctic Glacier, Astellas Pharma, Baxter International, Boehringer Ingelheim, Cardinal Health, CVS Caremark, Edwards Lifesciences, Fortune Brands Home & Security, and Potash Corporation of Saskatchewan. Mike is on the adjunct law faculty at Loyola University Chicago where he teaches antitrust law. He is a member of the board of advisors of the Institute for Consumer Antitrust Law Studies and the Midwest Antitrust Colloquium. He has written extensively on antitrust law matters for academic and trade journals and delivered addresses on competition issues for conferences in the U.S. and abroad.

Distinctions

Linked authors

Jones Day (Cleveland)
Jones Day (Chicago)
Jones Day (Washington DC)
Jones Day (Chicago)
Jones Day (Washington DC)
Jones Day (Washington DC)
Jones Day (Washington DC)
Jones Day (Washington DC)

Articles

974 Bulletin

Bevin M.B. Newman, Geoffrey D. Oliver, Michael Sennett The Court of Appeal for the District of Columbia rejects a challenge to an FTC rule that makes the HSR Act reporting requirements cover pharmaceutical patent licenses that transfer all commercially significant rights (PhRMA)

95

The D.C. Circuit has rejected a challenge by the Pharmaceutical Research and Manufacturers of America ("PhRMA") to an FTC rule that makes the HSR Act reporting requirements cover pharmaceutical patent licenses that transfer "all commercially significant rights." The rule, adopted in 2013, (...)

Michael H. Knight, Michael Sennett, Philip A. Proger The US FTC releases a summary of its new report on pharma patent litigation finding an increase in "reverse payment" settlements based on expanded definition of "payments"

566

With the Supreme Court set to address the validity of "reverse payment" settlements of pharmaceutical patent litigation, the FTC released a summary of its new report, announcing that in 2012 drug companies entered "a record number" of such settlements. However, the underlying data and analysis (...)

Kathryn M. Fenton, Michael Sennett, Pamela L. Taylor The U.S. FTC brings an administrative action alleging price fixing and other anticompetitive behavior involving three of the largest suppliers of ductile iron pipe fittings (Star Pipe Products, Sigma Corporation, McWane)

57

The FTC has brought an FTC administrative action alleging price fixing and other anticompetitive behavior involving three of the largest U.S. suppliers of ductile iron pipe fittings (DIPF), which are used in municipal water systems. It now has published for public comment a proposed consent (...)

Michael Sennett, Paula W. Render, Thomas Demitrack The US Supreme Court leaves in place third circuit rule welcoming challenges to foreign conduct into U.S. Courts (Animal Science)

81

This week the U.S. Supreme Court announced it would not review a Third Circuit decision (Animal Science) that made it easier for antitrust plaintiffs to bring claims in U.S. courts for conduct occurring overseas under the Foreign Trade Antitrust Improvements Act (“FTAIA”). The Supreme Court’s (...)

Michael Sennett, Paula W. Render, Thomas Demitrack A US District Court denies defendants’ motion to dismiss regarding indirect purchaser claims based on foreign sales (TFT-LCD Antitrust Litigation)

90

This article has been nominated by readers for the business category, general antitrust section of the 2012 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Recent decisions by the Third Circuit and the Northern District of California make it easier for (...)

Michael Sennett, Paula W. Render, Thomas Demitrack A US Court of Appeals holds that the Foreign Trade Antitrust Improvements Act imposes a substantive merits limitation rather than a jurisdictional bar (Animal Science Products/China Minmetals)

85

This article has been nominated by readers for the business category, general antitrust section of the 2012 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Recent decisions by the Third Circuit and the Northern District of California make it easier for (...)

Send a message